Septum Resection Versus Expectant Management in Women with a Septate Uterus: An International Multicentre Open-Label Randomized Controlled Trial

J. F.W. Rikken, C. R. Kowalik, M. H. Emanuel, M. Y. Bongers, T. Spinder, F. W. Jansen, A. G.M.G.J. Mulders, R. Padmehr, T. J. Clark, H. A. Van Vliet, M. D. Stephenson, F. Van Der Veen, B. W.J. Mol, M. Van Wely, M. Goddijn

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

Septate uterus, a congenital uterine anomaly, affects approximately 0.2% to 2.3% of women of reproductive age and is associated with increased risk of subfertility, pregnancy loss, and preterm birth. The standard treatment for septate uterus is hysteroscopic septum resection, although various obstetric and gynecologic academic societies differ in their support of the procedure, often citing inadequate evidence of effectiveness for a reason to avoid surgery.
Original languageEnglish
Pages (from-to)412-413
Number of pages2
JournalObstetrical and Gynecological Survey
Volume76
Issue number7
DOIs
Publication statusPublished - Jul 2021

Fingerprint

Dive into the research topics of 'Septum Resection Versus Expectant Management in Women with a Septate Uterus: An International Multicentre Open-Label Randomized Controlled Trial'. Together they form a unique fingerprint.

Cite this